Publicaciones en colaboración con investigadores/as de Universidad de Jaén (54)

2024

  1. Associations between the severity of menopausal symptoms and musculoskeletal pain in postmenopausal Portuguese women

    International Journal of Gynecology and Obstetrics, Vol. 165, Núm. 1, pp. 138-147

2023

  1. Associations between the impact of menopausal symptoms and fall-related self-efficacy

    Menopause (New York, N.Y.), Vol. 30, Núm. 4, pp. 421-426

  2. Effectiveness of Telemedicine for Reducing Cardiovascular Risk: A Systematic Review and Meta-Analysis

    Journal of Clinical Medicine, Vol. 12, Núm. 3

2022

  1. Antitumor Effect of Traditional Drugs for Neurological Disorders: Preliminary Studies in Neural Tumor Cell Lines

    Neurotoxicity Research, Vol. 40, Núm. 6, pp. 1645-1652

2019

  1. Double origin of the extensor hallucis longus muscle: a case report

    Surgical and Radiologic Anatomy, Vol. 41, Núm. 12, pp. 1421-1423

2018

  1. Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review

    Nutrition and Cancer, Vol. 70, Núm. 4, pp. 569-578

  2. Proteomic biomarkers in body fluids associated with pancreatic cancer

    Oncotarget, Vol. 9, Núm. 23, pp. 16573-16587

  3. Simvastatin exerts antiproliferative and differentiating effects on MG63 osteoblast-like cells: Morphological and immunocytochemical study

    Journal of Periodontal Research, Vol. 53, Núm. 1, pp. 91-97

2017

  1. Gastrointestinal stromal tumours: An actualized overview

    European Journal of Anatomy, Vol. 21, Núm. 2, pp. 97-112

  2. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study

    European Journal of Pharmaceutical Sciences, Vol. 102, pp. 24-34

  3. Paclitaxel-loaded hollow-poly(4-vinylpyridine) nanoparticles enhance drug chemotherapeutic efficacy in lung and breast cancer cell lines

    Nano Research, Vol. 10, Núm. 3, pp. 856-875

  4. Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Current status of immunotherapy treatments for pancreatic cancer

    Journal of Clinical Gastroenterology, Vol. 50, Núm. 10, pp. 836-848

  2. Last advances in nanocarriers-based drug delivery systems for colorectal cancer

    Current Drug Delivery, Vol. 13, Núm. 6, pp. 830-838

2015

  1. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(Butylcyanoacrylate) nanoparticles

    International Journal of Nanomedicine, Vol. 10, pp. 1291-1306

  2. Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles

    Drug Design, Development and Therapy, Vol. 9, pp. 6433-6444

  3. Microenvironmental modulation of decorin and lumican in temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells

    PLoS ONE, Vol. 10, Núm. 7

  4. Nanopartículas Magnéticas en el Diagnóstico y Tratamiento del Cáncer

    Actualidad médica, Tomo 100, Núm. 796, pp. 139-145

  5. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer

    AAPS Journal, Vol. 17, Núm. 4, pp. 918-929

  6. Temozolomide resistance in glioblastoma cell lines: Implication of MGMT, MMR, P-glycoprotein and CD133 expression

    PLoS ONE, Vol. 10, Núm. 10